Reply to "At what price decreased mortality risk?"

Affiliations

¹ Exponent, Inc., 3440 Market St, Suite 600, Philadelphia, PA, 19104, USA. kong@exponent.com.
² Oklahoma Spine, Edmond, OK, USA.
³ Exponent, Inc., 3440 Market St, Suite 600, Philadelphia, PA, 19104, USA.
⁴ Exponent, Inc., Menlo Park, CA, USA.
⁵ Massachusetts General Hospital, Boston, MA, USA.

Comment

K L Ong et al. Osteoporos Int. 2018 Aug.

. 2018 Aug;29(8):1929-1930.

doi: 10.1007/s00198-018-4551-4. Epub 2018 May 3.

¹ Exponent, Inc., 3440 Market St, Suite 600, Philadelphia, PA, 19104, USA. kong@exponent.com.
² Oklahoma Spine, Edmond, OK, USA.
³ Exponent, Inc., 3440 Market St, Suite 600, Philadelphia, PA, 19104, USA.
⁴ Exponent, Inc., Menlo Park, CA, USA.
⁵ Massachusetts General Hospital, Boston, MA, USA.

No abstract available

Comment on

Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty "sham" trials?
Ong KL, Beall DP, Frohbergh M, Lau E, Hirsch JA. Ong KL, et al. Osteoporos Int. 2018 Feb;29(2):375-383. doi: 10.1007/s00198-017-4281-z. Epub 2017 Oct 24. Osteoporos Int. 2018. PMID: 29063215 Free PMC article.
At what price decreased mortality risk? : Response to 'Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty "sham" trials?'.
Rodriguez AJ, Ebeling PR. Rodriguez AJ, et al. Osteoporos Int. 2018 Aug;29(8):1927-1928. doi: 10.1007/s00198-018-4550-5. Epub 2018 May 3. Osteoporos Int. 2018. PMID: 29725714 No abstract available.